Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response in Newly Diagnosed Chronic-phase cronic Myeloid Leukemia in Brasil: 24-months follow-up

Marcia Dias Alves, MBA, John Coombs, PharmD, MBA, Jefferson Ruiz, MD, Joice Valentim, PhD, Marta M. Lemos, MD

Blood (2011) 118 (21): 4216.

https://doi.org/10.1182/blood.V118.21.4216.4216

Published: 2011

Journal Articles

Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response In Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia In Brazil

Marcia Dias Alves, MBA, John Coombs, PharmD, MBA, Jefferson Ruiz, MD, Joice Valentim, PhD, Marta M. Lemos, MD

Blood (2010) 116 (21): 1520.

https://doi.org/10.1182/blood.V116.21.1520.1520

Published: 2010

Journal Articles

Imatinib Mesilate Versus Allogeneic Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia in First Chronic Phase - A Brazilian Point of View.

Henrique Bittencourt, MD, Vaneuza Funke, MD, Laura Fogliatto, MD, Simone Magalhaes, MD, Daniela Setubal, MD, Alessandra Paz, MD, Antonio V. Macedo, MD, Jefferson Ruiz, MD, Ana Paula Azambuja, MD, Lucia M.R. Silla, MD, Nelma Clementino, MD, Ricardo Pasquini, MD

Blood (2007) 110 (11): 1096.

https://doi.org/10.1182/blood.V110.11.1096.1096

Published: 2007

Journal Articles

Risk Factors for Graft Failure and Mortality after HLA-Matched Sibling Donor Transplant for Severe Aplastic Anemia in Brazil.

Ricardo Pasquini, MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Marco A. Bitencourt, MD, Jefferson Ruiz, MD, Judith Marsh, MD, Mark Walters, MD, Mary Eapen, MBBS

Blood (2007) 110 (11): 622.

https://doi.org/10.1182/blood.V110.11.622.622

Published: 2007

Journal Articles

Optimizing Results of Unrelated Donor Hematopoietic Stem Cell Transplantion in Developing Countries: Young Age and Early Disease as Positive Factors for Survival.

Vaneuza A.M. Funke, MD, MS, Elenaide C. Nunes, MD, Eliane Cezario, MD PHD, Jefferson Ruiz, MD, Daniela C. Setubal, MD, Michel M. Oliveira, MD, Carmem M.S. Bonfim, MD, Marco A. Bitencourt, MD MS, Claudia Pettengil, MD, Larissa Medeiros, MD, Heliz Regina A. Neves Datamager, MS, Jose Zanis Neto, MD PHD, Carlos R. Medeiros, MD MS, Ricardo Pasquini, MD PHD

Blood (2006) 108 (11): 5404.

https://doi.org/10.1182/blood.V108.11.5404.5404

Published: 2006

Journal Articles

Long Term Results of Allogeneic Stem Cell Transplant for CML in Pediatric Patients: A Study of 50 Cases Transplanted over 20 Years in a Single Institution.

Vaneuza A.M. Funke, MD, MS, Claudia Pettengil, MD, Carmem M.S. Bonfim, MD, Jefferson Ruiz, MD, Marco A. Bitencourt, MD MS, Daniela C. Setubal, MD, Elenaide C. Nunes, MD, Michel M. Oliveira, MD, Ana Paula Azambuja, MD, Denise H. Lima, ARNP, Keiko T. Kojo, ARNP, Heliz Regina A. Neves Datamanager, MS, Jose Zanis Neto, MD, PHD, Carlos R. Medeiros, MD MS, Ricardo Pasquini, MD, PHD

Blood (2006) 108 (11): 5361.

https://doi.org/10.1182/blood.V108.11.5361.5361

Published: 2006

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria (PNH): Long Term Follow up of 48 Patients in a Single Institution.

Jefferson Ruiz, MD, Larissa A. Medeiros, MD, Vaneuza A.M. Funke, MD MS, Carmem M.S. Bonfim, MD, Marco A. Bitencourt, MD MS, Daniela C. Setubal, MD, Claudia Pettengil, MD, Elenaide C. Nunes, MD, Michel M. Oliveira, MD, Jose Zanis Neto, MD PHD, Carlos R. Medeiros, MD MS, Mariester Malvezzi, MD MS, Ricardo Pasquini, MD PHD

Blood (2006) 108 (11): 3762.

https://doi.org/10.1182/blood.V108.11.3762.3762

Published: 2006

Journal Articles

Gleevec as Therapy for CML Relapsed after Allogeneic Stem Cell Transplantation: High Rate of BCR-ABL PCR Negativity and Donor Graft Reconstitution.

Vaneuza A.M. Funke, MD, MS, Samir K. Nabhan, MD, Michel M. Oliveira, MD, Jefferson Ruiz, MD, Daniela C. Setubal, MD, Ana Paula Azambuja, MD, Denise H. Lima, ARNP, Terezinha K. Kojo, ARNP, Henrique Bitencourt, MD, Nelson Hamerschlak, MD, Nelma Clementino, MD, Heliz Regina A. Neves, MS, Ricardo Pasquini, MD PHD

Blood (2006) 108 (11): 3671.

https://doi.org/10.1182/blood.V108.11.3671.3671

Published: 2006

Journal Articles

Treatment of 287 Patients(pts) with Severe Aplastic Anemia(SAA) Using Cyclosporine-A(Csa) and Prednisone(Pred): 15 Year Follow-Up from a Single Instituition.

Marco A. Bitencourt, MD, Carmem M.S. Bonfim, MD, Jefferson Ruiz, MD, Daniela C. Setubal, MD, Vaneuza M. Funke, MD, Jose Zanis-Neto, MD, Carlos R. deMedeiros, MD, Ricardo Pasquini, MD

Blood (2004) 104 (11): 2816.

https://doi.org/10.1182/blood.V104.11.2816.2816

Published: 2004

Journal Articles

Unrelated Donor Stem Cell Transplantation for 36 Patients(pts) with Fanconi Anemia(FA): A Single Center Experience.

Carmem M.S. Bonfim, MD, Marco A. Bitencourt, MD, Daniela C. Setubal, MD, Vaneuza A. Funke, MD, Carlos R. deMedeiros, MD, Jefferson Ruiz, MD, Mary E. Flowers, MD, Jose Zanis-Neto, MD, Ricardo Pasquini, MD

Blood (2004) 104 (11): 5171.

https://doi.org/10.1182/blood.V104.11.5171.5171

Published: 2004

Journal Articles

Five Years Update Results of Basiliximab (BAMAB) Therapy for Acute Refractory Graft Versus Host Disease (AGVHD).

Vaneuza A.M. Funke, MD, Carmem M. Bonfim, MD, Marco A. Bitencourt, MD, Daniela C. Setubal, MD, Jefferson Ruiz, MD, Carlos R. Medeiros, MD, Jose Z. Neto, PhD, Ricardo Pasquini, PhD

Blood (2004) 104 (11): 5083.

https://doi.org/10.1182/blood.V104.11.5083.5083

Published: 2004

NARROW

Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response in Newly Diagnosed Chronic-phase cronic Myeloid Leukemia in Brasil: 24-months follow-up

Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response In Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia In Brazil

Imatinib Mesilate Versus Allogeneic Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia in First Chronic Phase - A Brazilian Point of View.

Risk Factors for Graft Failure and Mortality after HLA-Matched Sibling Donor Transplant for Severe Aplastic Anemia in Brazil.

Optimizing Results of Unrelated Donor Hematopoietic Stem Cell Transplantion in Developing Countries: Young Age and Early Disease as Positive Factors for Survival.

Long Term Results of Allogeneic Stem Cell Transplant for CML in Pediatric Patients: A Study of 50 Cases Transplanted over 20 Years in a Single Institution.

Paroxysmal Nocturnal Hemoglobinuria (PNH): Long Term Follow up of 48 Patients in a Single Institution.

Gleevec as Therapy for CML Relapsed after Allogeneic Stem Cell Transplantation: High Rate of BCR-ABL PCR Negativity and Donor Graft Reconstitution.

Treatment of 287 Patients(pts) with Severe Aplastic Anemia(SAA) Using Cyclosporine-A(Csa) and Prednisone(Pred): 15 Year Follow-Up from a Single Instituition.

Unrelated Donor Stem Cell Transplantation for 36 Patients(pts) with Fanconi Anemia(FA): A Single Center Experience.

Five Years Update Results of Basiliximab (BAMAB) Therapy for Acute Refractory Graft Versus Host Disease (AGVHD).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only